Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results June 2, 2010

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Victoza	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Kalbitor	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Intuniv	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Fanapt	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Effient	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Ampyra	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Xifaxan 550	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Cayston	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Renvela	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Byetta	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Invega Sustenna	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Multaq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Twynsta	New Drug Appeal	Require Prior Approval	Prior Approval Required
Zemplar	New Drug Appeal	Require Prior Approval	Prior Approval Required
Toviaz	New Drug Appeal	Require Prior Approval	Prior Approval Required
Vivitrol	New Drug Appeal	Removed from Agenda Prior to Mtg	Prior Approval Required

Footer